Hormone Replacement Therapy products provide symptom relief from conditions arising due to hormonal changes associated with menopause, andropause and others. These therapies help alleviate symptoms such as hot flashes, night sweats, mood swings and others through administration of hormones like estrogen, progesterone and testosterone.
The global Hormone Replacement Therapy Market is estimated to be valued at US$ 16460.66 Mn in 2023 and is expected to exhibit a CAGR of 4.7% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
One of the key trends driving the growth of the Global Hormone Replacement Therapy Market Size is the increasing adoption of customized therapy. With growing awareness, customers are increasingly demanding therapy customized to their individual needs and symptoms. This has led manufacturers to offer therapy options which can be customized based on the severity of symptoms, lifestyle and other factors. Customized therapy enables precise dosage and type of hormones required by an individual. It has proven to be more effective in relieving symptoms compared to generic hormone regimens. The customized therapy trend is expected to continue and drive significant demand over the forecast period.
Segment Analysis
The global hormone replacement therapy market is segmented into hormone type, route of administration, application, and distribution channel. Based on hormone type, the estrogen hormone replacement therapy segment holds the largest share as estrogen is responsible for development and maintenance of female sexual characteristics. It reduces the symptoms of menopause, helps protect bones, and reduces the long-term risks of heart disease, colon cancer, and Alzheimer's disease.
Key Takeaways
The global hormone replacement therapy market is expected to witness high growth. The global Hormone Replacement Therapy Market is estimated to be valued at US$ 16460.66 Mn in 2023 and is expected to exhibit a CAGR of 4.7% over the forecast period 2024 to 2031.
North America region currently dominates the hormone replacement therapy market and is expected to continue its dominance during the forecast period. Due to high awareness among people about menopause management and treatments. This is majorly attributed to growing incidence of hormonal disorders and increasing adoption of hormone replacement therapy drugs in countries like the US and Canada. According to estimates, around 4.5 million American women undergo menopause each year.
Key players
Key players operating in the hormone replacement therapy market are PlayNetwork, Inc., TouchTunes Music Corporation, Sirius XM Holdings, Inc., Almotech Media Solutions, Imagesound, Easy on Hold, Soundnet Limited (Soundjack), Xenox Music & Media B.V., Qsic Pty Ltd., Express Melody, OpenEar Music, Auracle Sound, Cloud Cover Music, and Mood Media Corporation.
Get More Insights On This Topic: https://www.pressreleasebulletin.com/hormone-replacement-therapy-market-size-share-analysis-2023-2030/
